5V7.F VENTRIPOINT DIAGNOSTICS
- Market cap
- EUR 6.72M
- P/E
- -
- P/B
- 6.73x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 5V7.F undervalued?
Graham numberThe Graham number of VENTRIPOINT DIAGNOSTICS cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
VENTRIPOINT DIAGNOSTICS fundamental analysis
No fundamental analysis for VENTRIPOINT DIAGNOSTICS yet.
VENTRIPOINT DIAGNOSTICS stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About VENTRIPOINT DIAGNOSTICS
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D an…
Full company profileVENTRIPOINT DIAGNOSTICS financial statements
VENTRIPOINT DIAGNOSTICS annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 68.2K | 49.2K | 95.2K | 180K |
| Gross Profit | 0.00 | 57.8K | 42.4K | 95.2K | 180K |
| Operating Income | -3.64M | -4.80M | -4.87M | -4.80M | -3.40M |
| EBITDA | - | -4.79M | -4.75M | -4.76M | -2.67M |
| Net Income | -3.88M | -4.87M | -4.87M | -4.92M | -3.20M |
| EPS | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 |
| Balance Sheet | |||||
| Total Assets | 9.54M | 5.98M | 1.88M | 658K | 472K |
| Total Liabilities | 1.21M | 1.42M | 1.69M | 3.64M | 4.59M |
| Shareholders' Equity | 8.33M | 4.55M | 190K | -2.98M | -4.12M |
| Cash & Short-term Investments | 9.27M | 5.19M | 1.29M | 60.5K | 55.4K |
| Cash Flow | |||||
| Operating Cash Flow | -3.15M | -4.14M | -3.80M | -3.39M | -1.55M |
| Capital Expenditure | 4.26K | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -3.15M | -4.14M | -3.80M | -3.39M | -1.55M |
| Ratios | |||||
| ROE | -46.6% | -107.0% | -2,568.2% | - | - |
| ROA | -40.7% | -81.5% | -258.7% | -747.6% | -677.9% |
| Net Profit Margin | - | -7,148.3% | -9,905.7% | -5,169.1% | -1,778.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
VENTRIPOINT DIAGNOSTICS dividends
VENTRIPOINT DIAGNOSTICS has not paid dividends in the last 5 fiscal years.
Who owns VENTRIPOINT DIAGNOSTICS
- Insiders 1.59%
- Institutions 0.00%
- Public & others 98.41%
- Shares outstanding 195M
- Free float 190M
VENTRIPOINT DIAGNOSTICS company profile
- Company name
- VENTRIPOINT DIAGNOSTICS
- Ticker
- 5V7.F
- ISIN
- CA92281P2008
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- 18 Hook Avenue, Toronto, ON, Canada, M6P 1T4
- Phone
- 416 848 4156
- Website
- ventripoint.com
About VENTRIPOINT DIAGNOSTICS
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
VENTRIPOINT DIAGNOSTICS management
6- Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.Executive Chairman & Corporate Secretary · born 1952
- Mr. Hugh MacNaughtCEO, President & Director
- Mr. David Swetlow C.A., CPAChief Financial Officer
- Mr. Hirotaka KatagiriCTO & Business Development Division Director
- Mr. Matt DobsonMarketing Director
- Mr. Jim GrabaApplication Specialist & Chief Trainer